Business
Important COVID-19 Safety Measures for Sernova's 2020 Annual Meeting of Shareholders
(via TheNewswire) LONDON, ONTARIO - TheNewswire - April 21, 2020 - Sernov...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Important COVID-19 Safety Measures for Sernova's 2020 Annual Meeting of Shareholders(via TheNewswire)\n \n \nLONDON, ONTARIO - TheNewswire - April 21, 2020 - Sernova Corp. (TSXV:SVA)(OTC:SEOVF)(FSE:PSH), a clinical-stage regenerative medicine therapeutics company, announced today that it is implementing safety measures for its upcoming Annual Meeting of Shareholders (\"AGM\") to be held in Vancouver, BC on April 30, 2020, in response to public health authority guidelines issued concerning the COVID-19 pandemic. \n\n\n \nPublic health authorities across Canada continue to advise that both in-person contact and the congregation of groups be minimized in order to mitigate the risk of COVID-19 exposure or infection. Accordingly, shareholders are requested and strongly encouraged to vote electronically or by proxy on the matters before the meeting rather than attending the AGM in person. Voting instructions have been mailed to shareholders, and AGM related documents are accessible at www.sernova.com/investor/agm/. Immediately following the formal AGM, Sernova will host a conference call, and Dr. Philip Toleikis, President and CEO, will provide an update on Sernova's activities and respond to shareholder questions. Questions may be submitted to [email protected] prior to the call.\n\n\n \n\"The health and well-being of our shareholders, employees, collaborators, and communities, as well as preventing the spread of the COVID-19 virus is of utmost importance. We have been closely monitoring the COVID-19 situation and updating our company policies accordingly to make proactive adjustments and continue operations while doing our part to help 'flatten the curve.' We appreciate our shareholders' cooperation and understanding as the world navigates through these unprecedented times,\" said Dr. Philip Toleikis, President and CEO of Sernova Corp.\n\n\n \nThe conference call details for the Annual Meeting of Shareholders are set out below. \n\n \n \nUS Toll-Free: + 1-877-366-0711\n\n \n \nCanada Toll-Free: + 1-866-627-1651\n\n \n \nInt'l Toll-Free: + 1-302-709-8446\n\n \n \nThe conference participant passcode is 109 985 50. Following the conference call, a recording will be available at www.sernova.com/investor/agm\n\n \n \nABOUT SERNOVA'S CELL POUCH SYSTEM\n\n\n \nThe Cell Pouch, as part of the Cell Pouch System, is a novel, proprietary, scalab...